Actively Recruiting
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-04
30
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, non-pharmacological, spontaneous, single-center, interventional study.
CONDITIONS
Official Title
Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- BMI 6 40 without comorbidities or BMI 6 35 with at least one comorbidity
- Age between 18 and 65 years
- Written informed consent obtained
You will not qualify if you...
- Severe psychiatric illness in the decompensation phase
- Drug or alcohol abuse
- Unwillingness to follow periodic checkups and a dietary regimen
- Pregnancy or lactation
- Obesity caused by other endocrine disorders or medications
- Diabetes mellitus of any type
- Malignant tumors or ongoing acute illness
- Organ failure or chronic central nervous system and kidney disease
- Electrolyte imbalances
- Use of drugs affecting the pituitary-adrenal axis, diuretics, antipsychotics, psychopharmacological treatments, GLP1 receptor agonists, or estro-progestin therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
U
Uberto Pagotto, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here